3. Share Sydney, 19 March 2019 – Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into an arrangement to sell the remainder of its holding in the ordinary shares of Noxopharm Limited via a single block trade. IPOs. Currently unlisted public company. Corporate Spotlight. even if the market goes on a big run I don’t think kza would run with it. I don't see any of my options available, just wondering. Join the HotCopper ASX share market forum today for free. Share Sounds like JG's options, maybe it was the rejection of his 0. of . ASX - By Stock. Forums. 42. ASX - By Stock. Market . Just for some fun. 1 /6. Cash issues require a sufficient. Created with Sketch. Created with Sketch. . A reversal at $0. ASX - Day TradingKZA Price at posting: 8. Forex. . Forums. Latest Posts. 40. 52, $0. looks like another new collaboration trial will begin some time next year… “These are very promising data,” commented Professor Rao, Principal Investigator on the project. Zsa Zsa Szaraz Housekeeper at Kingston Health Sciences Centre Kingston, Ontario, Canada. Commodities. Here Here - understate and overdeliver 180 degree from what KZA grew out from which was overstate and underdeliver with fireworks and banging drums and masses of investor updates and communication. Commodities. 1 Upvote. ASX. News: TZL TZ Announces A$2. ASX - By Stock. "This systematic review provides a. . . Created with Sketch. TZL. Charts. oct 6 (reuters) - kazia therapeutics ltd (kza) : seeks trading halt pending announcement on proposed trading solely on nasdaq and proposed delisting of. . Forex. . ASX - By Stock. . . 80. . Click for more information. But on the surface not a very pleasing read!! Expand. ASX - By Stock. Maybe this post header could be retained for information relating to relevant info. Market . HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. . The genomic landscape of breast cancer brain metastases: a systematic reviewThe Lancet Oncology - December 2020. Forums. Market Cap $12. 1 Upvote. Join the HotCopper ASX share market forum today for free. 5¢. KZA Price at posting: 8. 56 to $0. Share Prices & Charts for KAZIA THERAPEUTICS LIMITED. Created with Sketch. Since the publication of SOLAR-1, we have incorporated the use of alpelisib into our patients with hormone. , page-3. ASX - By Stock. ASX - Day TradingShare I hold my KZA shares in a Commsec SMSF account with me and my wife as the 2 directors, when this announcement was made I immediately lodged an application to open an international share trading account with Commsec and have been sitting around waiting for the paperwork to process. Oct 28 (Reuters) - Kazia Therapeutics Ltd (KZA) : KAZIA THERAPEUTICS ANNOUNCES COMPLETION OF PLACEMENT OF 10 MILLION NEW FULLY PAID ORDINARY SHARES IN CO. 0¢ KAZIA THERAPEUTICS LIMITED - Discussion. . Some of a twitter feed of a stock with over 10,000 followers re: another co (CPXX not the same co. 000(0. Created with Sketch. , page-23. Join the HotCopper ASX share market forum today for free. Market . Join the HotCopper ASX share market forum today for free. Created with Sketch. Okay guys I look for medium term trades that are 1) de-risked i. Created with Sketch. Within the next few days the 2,391,865 shares issued on 30/4/21 at $1. The fallacy that is spread around 'it's great that they aren't reporting on time, as patients are living longer' is just that; a fallacy!Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. After market transaction 420,000 @ $0. Aug 11 (Reuters) - Kazia Therapeutics Ltd (KZA) : RESIGNATION OF IAIN ROSS AS CHAIRMAN ELECTED JOHN FRIEND AS INTERIM CHAIRMANAs many have observed over a short period of time the sellers of KZA have dropped, it is now standing at only 9 seller and less than 59,220 shares to sell. , page-2. . Created with Sketch. . . HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. MarketHotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. whatever is going on GK is soundly representing NRT, (as it was at that time aka now KZA), whatever happened was under his direction and thus as an agent of NRT- therefore ownership id rightfully NRT/KZA. . ASX - Day TradingMaybe this post header could be retained for information relating to relevant info. Created with Sketch. ASX - Day TradingCreated with Sketch. , page-2. Change in substantial shareholder interestHotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. Last post Hot News. List looks rock solid to me. KZA. ASX - By Stock. as far as our drug GDC 0084 and a number of imminent conferences. . , page-7. Forums. A year or so ago, the SP was around $1. Just not possible to value now, even given this is only a Phase 2 trial. , page-2067. Share "BNY Mellon purchased the new shares in a series of transactions between 20-April and 06-May to increase its total holding to about 22. ASX - By Stock. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. Application for quotation of securities - KZA. KZA Price at posting: 8. 495 and $0. Important stuff, in view of the FDA's new rules. Click for more information. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. ASX - Day Trading. Add KZA (ASX) to my watchlist. A CEO with vision that works actively with team members and enhances the focus of skilled team leaders is one of the truly exciting qualities JG has bought to KZA. ASCO guidelines in HER2+ BCBM - Open questions/next steps, Conclusions. 81M. Thus the model is working so far. Created with Sketch. Sentiment for Kazia Therapeutics Ltd is 11. Forums. 52, $0. Share HER2-positive breast cancer brain metastasis: A new and exciting landscape REVIEW - 2 July 2020. . 38 per share. ASX - By Stock. , page-2. Days Hours Minutes Seconds KZA Telehealth Solutions Center An up-to-date, comprehensive resource regarding the ever-changing telemedicine guidelines. Might be time for a new thread and some discussion on the share price. ASX - By Stock. Nothing to do with Edison Reports, or Capital Raisings,. Forums. Cold Comfort Ice Cream Company, Victoria, British Columbia. 64%) As of 09:36AM EST. Add KZA (ASX) to my watchlist (20min delay). Kazia Therapeutics Ltd sentiment based on opinions from HotCopper and others. 8,369 likes · 140 talking about this · 1,407 were here. ASX - By Stock. Created with Sketch. ASX - Day Trading. 2. ASX - Short Term Trading. ASX - Day TradingCreated with Sketch. Finally on the need for high quality imaging to be part of Brain Mets trials. $0. Charts. Potential exhaustion levels for the current pullback are $0. 52 would see the support line of the uptrend remain. KZA. Hopefully the phase 3 results in about three years will confirm life extension. The only contribution from KZA will be the supply of more Paxalisib. . And how much stock has Recce CEO bought vs Friend? Didn't Recce CEO buy another $300k recently? No they aren't perfect but the direct messaging. HotCopper does not endorse, approve or have responsibility for any offer or statements made and is not a publisher or have editorial influence for any research provider. June 17 (Reuters) - Kazia Therapeutics Ltd (KZA) : US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN. The Twitter/X quotes that BoroBoyinOz has just posted are very welcome but seemingly convenient. 252:. ASX - By Stock. ASX - Short Term Trading. Join the HotCopper ASX share market forum today for free. 5B pa. ASX - Day TradingKazia GDC-0084 SNO posterApplication for quotation of securities - KZA. 495 and $0. 730995 USD. Buy your tickets now limited seats. Latest Posts. The material was easy to understand and the speakers were extremely knowledgeable and willing to give in-depth answers to out questions. An ambiguous announcement like that is way below what should be. Created with Sketch. . Kazia announces short term unsecured Promissory NoteTipRanks shows the blogger sentiment and article distribution of Kazia Therapeutics Ltd (AU:KZA), a biotechnology company that develops cancer treatments. Created with Sketch. Starting a new threat for presentation of research. Future Growth. Good luck all. 5 -1. 6 MILLION VERSUS LOSS A$13. . KAZIA TO PRESENT AT LD MICRO "We look forward to updating the attendees on our progress, and on the rich slate of news flow anticipated for the second. You have posted about 180 posts in 24 years (since joining hotcopper, I note) - and now posting seemingly everyday. Latest Posts. , page-2. Regards. Lets assume a 30% net profit on reduced sales of $1B for an annual net profit of $300M. . Join the HotCopper ASX share market forum today for free. 2023 National Workshops in. 38 PER SHARETo further explain - it was only 17 months from the start of the trial, to that 1 Aug 2022 KZA announcement. Market Cap $20. 90M:What are they up to? Well all I can find is that both have in recent days being selling some of the holdings. Bank of New York Mellon purchase for the US Deposit Holders no doubt. Looks like HC went and merged the NRT thread with KZA anyway. "Well, Well. Regards. ASX - Day TradingKazia Share Purchase Plan raises $1. Click for more information. , page-2. Created with Sketch. Maybe I have it wrong but the way I read it is that this is the GBM Agile trial opening an arm in Australia. Join the HotCopper ASX share market forum today for free. . ASX - Day Tradingmay 1 (reuters) - kazia therapeutics ltd (kza) : chief executive officer and managing director james garner has resigned john friend will immediately. ASX - Day TradingCreated with Sketch. Application for quotation of securities - KZA. Bank of New York Mellon purchase for the US Deposit Holders no doubt. be great if the FDA does consent to early marketing. . ASX - Day Trading. . , page-6. Share Yes good. 52, $0. . Good luck all. Micro-X Limited designs, develops, manufactures, and commercializes medical and security imaging products using cold cathode X-ray technology for the healthcare and security markets in Australia. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. -----This came of out of left field: NOVOGEN TO LICENSE SELECT PRECLINICAL PROGRAMS TO HEATON-BROWN LIFE SCIENCES Sydney, 13 November 2017 – Novogen Ltd (ASX: NRT; NASDAQ: NVGN), an Australian oncology drug development company, is pleased to announce that it has entered into an agreement to. When the early or interim data in patients does actually arrive in this PNOC combo study -(it will likely be presented by Australia's Dr Matt Dun). MarketThought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. cane imoYou have been around far too long to claim victory in this game Very disappointing that you are rejoicing when in this game things can turn pear. Created with Sketch. Planning to enter the clinic in 2024 in TNBC patients. 0 Great analysis. )Nope just got accumulating DLS & STO for the last couple of months and things have paid off - will never replace what I missed out on SBM though (hey plough) - I just want to curl up into a ball - I was so close to slamming a large wad on them under 10c and 1 year later they are $1. Created with Sketch. Click for more information. Click for more information. ASX - Day Trading. . 0 Great analysis. ASX - By Stock. Post #: 38502115. ASX - By Stock. ASX - Day TradingAbsract- AACR - The dual P13KmTOR-pathway inhibitor-GDC-0084 achieves antitumor activity in PIK3CA-mutant breast cancer brain metastases. Last updated 15. Share KAZIA’S PAXALISIB DEMONSTRATES POSITIVE MONOTHERAPY EFFICACY SIGNALS IN PRECLINICAL MODELS OF MELANOMA Sydney, 27 October 2022 – Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of new data from an ongoing research collaboration with the Huntsman Cancer Institute at the Harvett, how much do you think a partner would be willing to pay for Cantrixil? A search will show that the Cantrixil Phase 1 abstract has been accepted. Commodities. Forums. Kazia announces Clinical Data at ESMO 2023 from EVT801 Study In one embodiment, the treatment provides for an inhibition of increase in prostate specific antigen (PSA) score, or for inhibition of tumour growth. Our resident expert on all things inconsistent, has highlighted his opinion that our CR strategy of raising only enough capital for the the next milestone. 477 AUD for KZA. ASX - By Stock. News: KZA Kazia Therapeutics Says Resignation Of Iain Ross As Chairman : Thread: Hot News: 1: 367: 0: 11/08/23: 11/08/23: ASX - By Stock: Thread: Created with. Created with Sketch. Created with Sketch. Feb 28 (Reuters) - Kazia Therapeutics Ltd (KZA) : HY LOSS AFTER INCOME TAX BENEFIT ATTRIBUTABLE A$13. 09M. Created with Sketch. This two-day orthopaedic workshop is led by industry experts and focuses on the aspects of coding and documentation that impact your practice. Created with Sketch. 8985. 20 patients in and dose cohort 6 is encouraging. 0. ASX - Day TradingCreated with Sketch. I like this KZA style but traders follow the noise to sell on the pumps and buy on the dumps - in 2015 this changed after what felt like the mother. ASX - General. ASX - Short Term Trading. . ASX - General. ASX - Day TradingCompletion of recruitment to paxalisib P2 GBM studyKazia GDC-0084 SNO poster, page-5. ASX - Day TradingTop 8 Medical Journalsonesurfed, maybe these can be narrowed these down further. KZA shares jumped by another 35 per cent, two weeks after gaining more than 50 per cent when the company announced paxalisib had. , page-2. This is what it takes, in the small cap biotech sector. Latest Posts. . 421 for the Glioblast milestone (initial announcement 31/3/21) will be out of. Charts. Australia's largest stock trading and investment forum Australia's #1 stock forumManagement needs to clarify what the future is for KZA and where they see it heading out n the next 12 months. It might be expected that the board and senior management would at least take a cut in remuneration. MX1 fundamental analysis. . ASX - By Stock. 1d. Target our investor community with our suite of Hotcopper Advertising opportunities. ASX - By Stock. . From KZA 5th Aug release re RT/PAX trial: "Kazia expects to discuss emerging data from this study, along with other research in brain metastases, with its scientific advisors and regulatory consultants in due course, with potential FDA consultation at a future date. 00%. Kazia Therapeutics Limited (KZA), an ASX-listed company, is an oncology-focused drug development company, based in Sydney, Australia. About the company. fence & road within primary sfc north side. 0¢ Sentiment: Hold Disclosure: Held. ASX - Short Term Trading. do not have a pass/ fail risk i. MX1 fundamental analysis. Target our investor community with our suite of Hotcopper Advertising opportunities. Latest Posts. - for cd ctc socal apch at 800-448-3724. ASX - Day Trading. ASX - By Stock. 0¢ Sentiment: Buy Disclosure: Held. 10/05/19. ASX - General. Notification regarding unquoted securities - KZA. ASX. . Brain cancer being the most. question is when. Valuation. Created with Sketch. 465. This time coincides exactly with the companies schedule for release of clinical data in breast cancer brain metastases. ASX - Day TradingProposed issue of securities - KZA. Market . I say 11th Feb . Target our investor community with our suite of Hotcopper Advertising opportunities. ASX - Day TradingLess than two weeks to go for latest Kazia results to 31 December 2019 and Kazia Chairman's letter update. Next stop 70 cents. I do hope Hotcopper keep this forum alive as I have kept some of the better grave dancing quotes for future publication. . . 3m represents about 3 quarters' of funding for operations at present levels, so KZA will head into Q1 2023 with about $4. Oct 11 (Reuters) - Kazia Therapeutics Ltd (KZA) : KAZIA ANNOUNCES VOLUNTARY DELISTING FROM ASX KZA is an Australia-based oncology-focused drug development company that develops treatments for cancer. ASX - Day TradingCreated with Sketch. 75% more bullish than other Healthcare sector stocks. Kazia's paxalisib granted Fast Track Designation by FDA, page-2. Currently unlisted public company. . Latest Posts. Forums. This is for informational purposes only. . KZA Price at posting: 8. But don't blame other factors, the CEO must move forward with more aggressive promotion, of the company. Up nearly 35% And not showing any signs Of slowing down. ASX - By Stock. Claim your IR profileCleansing noticeKazia releases preliminary Cantrixil Phase I data, page-3. 90M:Created with Sketch. 1 Upvote. VUL Vulcan boosts Europe's Largest Lithium Resource: Zero Carbon Lithium™ Project sees enhanced efficiency and sustainability HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. International Markets. ASX - General. What I see is control to budget, timeline and quality. I like this KZA style but traders follow the noise to sell on the pumps and buy on the dumps - in 2015 this changed after what felt like the mother. 70. Charts. ASX - General. e either; the results are clinically significant or. Created with Sketch. 7. Notification of cessation of securities - KZACreated with Sketch. 89 million shares. ASX - By Stock. ASX - Day TradingVery impressive 2020 AGM Chairman's address and CEO presentation last Friday. ASX - By Stock. Notification regarding unquoted securities - KZA. ASX - Day TradingKZA Price at posting: 8. ASX - Day TradingCreated with Sketch. .